Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials

By afschroeder • September 30, 2025

Ahmed M, Hashmi TM, Shafiq A, Ashraf H, Jain H, Khanji MY, Providência R, Chahal AA, Rana JS, Farhan M, Ahmed R, Fudim M, Fonarow GC. Efficacy and safety of colchicine in patients with coronary artery disease: An updated meta-analysis of randomized controlled trials. Am Heart J Plus. 2025 Sep 13;59:100610. doi: 10.1016/j.ahjo.2025.100610. PMID: 41019029; PMCID: PMC12465056.

Tags: Cardiology/Epi, Colchicine, coronary artery disease, Inflammation, meta-analysis, Publications

High agreement of coronary artery calcification scores between full-dose (6.5 mSv) and reduced-dose (1.5 mSv) chest computed tomography: A retrospective analysis of COPDGene

Moore JM, Pratte KA, Ferguson C, Casaburi R, Iskander B, Abbasi A, Alapati P, Chilukuri S, Narashim A, Budoff MJ, Rossiter HB. High agreement of[...]

Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2 complex

Kang X, Zhao Y, Nelson SF, Pyle A, Lusis AJ, Touma M. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) maintains muscle progenitor identity by stabilizing the Ppp1r1b-lncRNA-PRC2[...]

Outcomes of Early Sodium-Glucose Cotransporter 2 Inhibitor Use in Takotsubo Syndrome: Insights from a Multicenter Real-World Cohort Study

Taha A, Mondal A, Sandhyavenu H, Atti L, Alhajji M, Thangjui S, Shaik BF, Thyagaturu H, Caccamo M, Fonarow GC, Balla S. Outcomes of Early[...]